Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Tell us about your organization

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-801-226-5120.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank you !

Access info about Virtual Care Platforms (Non-EMR) on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Premium Reports
Subject Expert

Contact KLAS

info@klasresearch.com

801.226.5120

KLAS - Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

Related Segments

Related Products

Related Vendors

 End chart zoom
Global (Non-US) Virtual Visit Solutions 2021
* A page refresh may be necessary to see the updated image
New

Global (Non-US) Virtual Visit Solutions 2021
Unprecedented Demand Leads to Broad Options

August 3, 2021 | Read Time: 7  minutes

Current Time Inside Cache Tag Helper: 8/5/2021 2:10:53 PM and Model.reportId = 1763

Across the globe, COVID-19 forced provider organizations to explore new ways to safely meet with and care for patients. While regulations may shift in the post-COVID world, most countries are unlikely to roll them back completely, meaning telehealth is here to stay. For this study, KLAS interviewed 113 organizations outside the US about their current state with and future plans for virtual visit technology. 90% have adopted virtual visit technology, and in total, they mentioned using or considering the commercial video visit platforms, public telehealth platforms, or video conferencing platforms of 56 different vendors. At the onset of the COVID-19 pandemic, organizations rolled out technology in a matter of weeks, and most plan to reevaluate these solutions in the near future. What types of platforms and which vendors are being used and considered most often? Who is likely to lose customers and why?

Thank you !

Access info about Virtual Care Platforms (Non-EMR) on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 8/5/2021 2:10:53 PM and Model.reportId = 1763

Key Findings:

  1. Microsoft Teams and Zoom (Both Cross-Industry Video Conferencing Platforms) Adopted Most Broadly amid Diverse Pool of Virtual Visit Solutions
  2. EMR-Centric Solutions Least Often Adopted but Most Likely to Be Retained
  3. Regional Insights, Europe: Attend Anywhere Struggles in the UK; Numerous Regional Solutions Preferred over Cross-Industry Solutions for Privacy Reasons
  4. Regional Insights, Middle East: Cross-Industry Solutions Preferred; Among Healthcare-Specific Vendors, Okadoc & VSee Lead Diverse Group
  5. Regional Insights, Canada: OTN Issues Fuel Interest in Other Solutions
  6. Regional Insights, Latin America & Asia/Oceania
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.